logo-loader
Althea Group Holdings Ltd

Althea enters UK medicinal cannabis market through acquisition

The company expects to supply medicinal cannabis to patients from around March 2019.

Cannabis growing
Althea is a patient-focused medical cannabis company and supplier of medical cannabis products

Althea Group Holdings Ltd (ASX:AGH) has entered the UK medicinal cannabis market with the acquisition of its new UK subsidiary, Althea MMJ UK Ltd.

The company will be one of the first companies to enter the medicinal cannabis market in that country following the November 2018 legislative change, enabling cannabis-based products to be prescribed by doctors.

Althea’s UK entry has been supported by Aphira Inc (TSX:APH) which has entered into a new cannabis product acquisition agreement and trademark licence agreement with Althea UK.

These agreements will provide Althea UK with high-quality and consistent medicinal cannabis supply allowing the company to focus on patient access and product distribution.

 

 

Improving patient access to medicinal cannabis

Althea CEO Joshua Fegan said: “The UK’s highly regulated framework for prescribing, supplying and possessing medicinal cannabis products is very similar to that of Australia.

“We know focusing on improving patient access to medicinal cannabis and educating medical practitioners on treatment is the key to establishing market share, so the UK market entry will be based on our three-phased business model successfully implemented in Australia.”

Since entering the Australian market in May 2018, 93 registered healthcare professionals are now prescribing Althea medicinal cannabis products to more than 328 patients across Australia.

This represents about 20% of the total market.

Globally unique approach

Fegan added: “Focused on early revenue generation through importation and distribution of products, the education of healthcare professionals and scalable long-term supply of high-quality products, our approach is unique globally.

“The model can be rolled out in other countries where patient access is similarly highly regulated.”

Althea plans to export Althea’s Australian manufactured products for UK distribution by 2020.

- Jessica Cummins 

Quick facts: Althea Group Holdings Ltd

Price: $0.79

Market: ASX
Market Cap: $126.79 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks flat as a pancake but CROP shares jump on first...

Cannabis stocks cruised into Friday flat as a pancake across North American markets. Buds today were CROP Infrastructure Corp (CSE:CROP) (OTCMKTS:CRXPF), True Leaf Brands Inc (CSE:MJ) (OTCMKTS:TRLFF), while the duds were TerrAscend Corp (CSE:TER) (OTCMKTS:TRSSF),...

21 hours, 38 minutes ago

2 min read